# Helicobacter Pylori Eradication With Clostridum Butyricum Capsule and Bacillus Coagulans Tablets

> **NCT03857425** · PHASE4 · COMPLETED · sponsor: **Xijing Hospital of Digestive Diseases** · enrollment: 150 (actual)

## Conditions studied

- Gastritis
- H Pylori Infection
- Dyspepsia

## Interventions

- **DRUG:** Clostridum Butyricum Capsule
- **DRUG:** Bacillus Coagulans Tablets
- **DRUG:** Clostridum Butyricum Capsule plus Bacillus Coagulans Tablets

## Key facts

- **NCT ID:** NCT03857425
- **Lead sponsor:** Xijing Hospital of Digestive Diseases
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-01
- **Primary completion:** 2019-08-31
- **Final completion:** 2019-09-15
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2019-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03857425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03857425, "Helicobacter Pylori Eradication With Clostridum Butyricum Capsule and Bacillus Coagulans Tablets". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03857425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*